Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02415933Not ApplicableCompleted

Child Protective Outcomes Among Ultra-poor Families in Burkina Faso

Role: collaborator

NCT02669654Phase 4Unknown

Effectiveness Trial of Day-care vs. Usual Care of Severe Pneumonia & Malnutrition in Children

Role: collaborator

NCT02348177Phase 4Completed

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Role: collaborator

NCT02130856Phase 3Completed

Newborn Kit to Save Lives in Pakistan

Role: collaborator

NCT03031236Not ApplicableCompleted

Reduce Childhood Maltreatment and Promote Development

Role: collaborator

NCT01994304Not ApplicableCompleted

Assessment and Evaluation of the Safe Childbirth Checklist --Phase II

Role: collaborator

NCT02148822Completed

Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia

Role: collaborator

All 7 trials loaded